NCT06896890 2025-03-26Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung CancerInhatarget TherapeuticsPhase 1/2 Recruiting32 enrolled